The european centre for disease prevention and control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use

Eurosurveillance

Volumn 17, Issue 46, 2012, Pages 1-16

  Zarb, P ^a,b   Coignard, B ^c   Griskeviciene, J ^d   Muller, A ^b   Vankerckhoven, V ^b   Weist, K ^d   Goossens, M M ^e   Vaerenberg, S ^e   Hopkins, S ^f   Catry, B ^e   Monnet, D L ^d   Goossens, H ^b   Suetens, C ^d  

^a MATER DEI HOSPITAL   (Malta)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GLYCOPEPTIDE; PENICILLIN DERIVATIVE; RIFAMPICIN;

ARTICLE; BLOODSTREAM INFECTION; CHILD; CLOSTRIDIUM DIFFICILE; DATA ANALYSIS; DATA COLLECTION METHOD; DISEASE ASSOCIATION; EMERGENCY CARE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL INFECTION; GRAM POSITIVE COCCI; HEALTH SURVEY; HOSPITAL; HOSPITAL INFECTION; HUMAN; INFANT; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; PROPHYLAXIS; PSYCHIATRY; PUBLIC HEALTH SERVICE; RISK FACTOR; SINGLE DRUG DOSE; SURGICAL INFECTION; URINARY TRACT INFECTION; WORKLOAD;

EID: 84870865115     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.17.46.20316-en     Document Type: Article

References (50)

1. European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report on communicable diseases in Europe 2008. Stockholm: ECDC; 2008. Available from: http://ecdc.europa.eu/en/publications/Publications/0812_SUR_ Annual_Epidemiological_Report_2008.pdf
2. Agodi A, Auxilia F, Barchitta M, Brusaferro S, D'Alessandro D, Montagna MT, et al. Building a benchmark through active surveillance of intensive care unit-acquired infections: the Italian network SPIN-UTI. J Hosp Infect. 2010;74(3):258-265.
3. Lambert M, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, et al. Clinical outcomes of healthcare-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis. 2011;11(1):30-38.
4. Wilson J, Ramboer I, Suetens C. Hospitals in Europe link for infection control through surveillance (HELICS). Inter-country comparison of rates of surgical site infection--opportunities and limitations. J Hosp Infect. 2007;65(Suppl 2):165-170.
5. Suetens C, Morales I, Savey A, Palomar M, Hiesmayr M, Lepape A, et al. European surveillance of ICU-acquired infections (HELICS-ICU): Methods and main results. J Hosp Infect. 2007;65 (Suppl 2):171-173.
6. Suetens C, Savey A, Labeeuw J, Morales I. The ICU-HELICS programme: Towards European surveillance of hospital-acquired infections in intensive care units. Euro Surveill. 2002;7(9):p 359. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=359
7. Improving Patient Safety in Europe (IPSE). The IPSE report 2005-2008. Lyon: Université Claude Bernard Lyon1; November 2009]. Available from http://www.ecdc.europa.eu/en/activities/surveillance/HAI/Documents/0811_IPSE_Technical_Implementation_Report.pdf
8. Gravel D, Taylor G, Ofner M, Johnston L, Loeb M, Roth VR, et al. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect. 2007;66(3):243-248.
9. Lanini S, Jarvis WR, Nicastri E, Privitera G, Gesu G, Marchetti F, et al. Healthcare-associated infection in Italy: Annual point-prevalence surveys, 2002-2004. Infect Control Hosp Epidemiol. 2009;30(7):659-665.
10. Struwe J, Dumpis U, Gulbinovic J, Lagergren A, Bergman U. Healthcare associated infections in university hospitals in Latvia, Lithuania and Sweden: a simple protocol for quality assessment. Euro Surveill. 2006;11(7):p 640. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=640
11. The RAISIN Working Group. "RAISIN" - a national programme for early warning, investigation and surveillance of healthcare-associated infection in France. Euro Surveill. 2009;14(46):p 19408. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19408
12. Reilly J, Stewart S, Allardice GA, Noone A, Robertson C, Walker A, Coubrough S. Results from the Scottish national HAI prevalence survey. J Hosp Infect. 2008;69:62-68.
13. Suetens C, Ammon A, Weist K, Sodano L, Monnet DL. Review of methods of national prevalence surveys of healthcare-associated infections in 17 European countries. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 16-19 May 2009; Helsinki, Finland. Clin Microbiol Infect. 2009;15(s4):P.624.
14. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Protocol version 4.3. Full scale survey and codebook. Stockholm: ECDC: 2012. Available from: http://www.ecdc. europa.eu/en/activities/surveillance/HAI/about_HAI-Net/Pages/PPS.aspx
15. Müller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. J Antimicrob Chemother. 2004;54(6):1122-1126.
16. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H. Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002). J Antimicrob Chemother. 2006;58(1):159-167.
17. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;355(9208):973-978.
18. Cooke DM, Salter AJ, Phillips I. The impact of antibiotic policy on prescribing in a London teaching hospital. a one-day prevalence survey as an indicator of antibiotic use. J Antimicrob Chemother. 1983;11(5):447-453.
19. Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: Report of 12 point-prevalence studies on antibiotic use in a University hospital. Scand J Infect Dis. 2002;34(1):56-60.
20. Ufer M, Radosević N, Vogt A, Palcevski G, Francetić I, Reinalter SC, et al. Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf. 2005;14(10): 735-739.
21. Usluer G, Ozgunes I, Leblebicioglu H. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.
22. Ciofi Degli, Atti ML, Raponi M, Tozzi AE, Ciliento G, Ceradini J, Langiano T. Point prevalence study of antibiotic use in a paediatric hospital in Italy. Euro Surveill. 2008;13(41):pii=19003. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19003
23. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496-1504.
24. Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues A, et al. European surveillance of antibiotic consumption (ESAC) point prevalence survey 2008: Paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother. 2010;6(10)5:2247-2252.
25. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, et al. Identification of targets for quality improvement in antimicrobial prescribing: The web-based ESAC point prevalence survey 2009. J Antimicrob Chemother. 2011;66(2):443-449.
26. Zarb P, Goossens H. European surveillance of antimicrobial consumption (ESAC): Value of a point-prevalence survey of antimicrobial use across Europe. Drugs. 2011;71(6):745-755.
27. Zarb P, Ansari F, Muller A, Vankerckhoven V, Davey PG, Goossens H. Drug utilization 75% (DU75%) in 17 European hospitals (2000-2005): Results from the ESAC-2 hospital care sub project. Curr Clin Pharmacol. 2011;6(1):62-70.
28. Ang L, Laskar R, Gray JW. A point prevalence study of infection and antimicrobial use at a UK children's hospital. J Hosp Infect. 2008;68(4):372-374.
29. O'Neill E, Morris-Downes M, Rajan L, Fitzpatrick F, Humphreys H, Smyth E. Combined audit of hospital antibiotic use and a prevalence survey of healthcare-associated infection. Clin Microbiol Infect. 2010;16(5):513-515.
30. Ider BE, Clements A, Adams J, Whitby M, Muugolog T. Prevalence of hospital-acquired infections and antibiotic use in two tertiary Mongolian hospitals. J Hosp Infect. 2010;75(3):214-219.
31. Hajdu A, Samodova OV, Carlsson TR, Voinova LV, Nazarenko SJ, Tjurikov AV, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect. 2007;66(4):378-384.
32. Maugat S, Thiolet J, L'Hériteau F, Gautier C, Tronel H, Metzger M, et al. Prévalence des traitements antibiotiques dansles établissements de santé, France 2006 [Prevalence of antibiotic treatments in healthcare facilities, France, 2006]. Bull Epidemiol Hebd. 2007;51-52:432-437. French. Available from: http://opac.invs.sante.fr/doc_num.php?explnum_id=3474
33. Council of the European Union. Council Recommendation of 9 June 2009 on patient safety, including the prevention and control of healthcare associated infections (2009/C 151/01). Available from: http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:C:2009:151:0001:0006:EN:PDF
34. Council of the European Union. Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:034:0013:0016:EN:PDF
35. Hospital in Europe Link for Infection Control through Surveillance (HELICS). Surveillance of surgical site infections. Protocol version 9.1. Lyon: HELICS; Sept 2004. Available from: http://www.ecdc.europa.eu/en/activities/surveillance/HAI/Documents/0409_IPSE_SSI_protocol.pdf
36. Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl 6): 2-18.
37. Nosocomial infection surveillance system for preterm infants on neonatology departments and intensive care units (Neo-KISS). Protokoll.Surveillance nosokomialer Infektionen bei Frühgeborenen mit einem Geburtsgewicht <1.500g. [Protocol. Surveillance of nosocomial infections in preterm infants with a birth weight <1,500 g]. Berlin: Institut für Hygiene und Umweltmedizin, Charité; Dec 2009. German. Available from: http://www.nrz-hygiene.de/fileadmin/nrz/download/NEOKISSProtokoll221209.pdf
38. Hospital in Europe Link for Infection Control through Surveillance (HELICS). Surveillance of nosocomial infections in intensive care units. Protocol version 6.1. Lyon: HELICS; Sept 2004. Available from:http://www.ecdc.europa.eu/en/activities/ surveillance/HAI/Documents/0409_IPSE_ICU_protocol.pdf
39. Geffers C, Baerwolff S, Schwab F, Gastmeier P. Incidence of healthcare-associated infections in high-risk neonates: results from the German surveillance system for very-low-birthweight infants. J Hosp Infect. 2008;68(3):214-221.
40. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-332.
41. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. The ATC/DDD system: International language for drug utilization research. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; Oct 2007. Available from: http://www.fhi.no/dav/a0fb3024e7.pdf
42. McCabe WR, Jackson GG. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med. 1962;110:847-853.
43. Goossens H. Expert-proposed European strategies to monitor and control infection, antibiotic use, and resistance in healthcare facilities. Lancet Infect Dis. 2011;11(5):338-540.
44. Pappachan JV, Millar B, Bennett ED, Smith GB. Comparison of outcome from intensive care admission after adjustment for case mix by the APACHE III prognostic system. Chest. 1999;115(3):802-810.
45. Rowan KM, Kerr JH, Major E, McPherson K, Short A, Vessey MP. Intensive Care Society's APACHE II study in Britain and Ireland--II: outcome comparisons of intensive care units after adjustment for case mix by the American APACHE II method. BMJ. 1993;307(6910):977-981.
46. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer. 2002;86(3):331-335.
47. Sax H, Pittet D. Interhospital differences in nosocomial infection rates: importance of case-mix adjustment. Arch Intern Med. 2002;162(21):2437-2442.
48. Reilly J, Stewart S, Allardice G, Cairns S, Ritchie L, Bruce J. Evidence-based infection control planning based on national healthcare-associated infection prevalence data. Infect Control Hosp Epidemiol. 2009;30(2):187-189.
49. Valintiliene R, Gailiene G, Berzanskyte A. Prevalence of healthcare-associated infections in Lithuania. J Hosp Infect. 2012;80(1):25-30.
50. Lyytikäinen O, Kanerva M, Agthe N, Möttönen T, Ruutu P; Finnish Prevalence Survey Study Group. Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect. 2008:69(3):288-294.